Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Therapeutic Drug Monitoring|June 10, 2025
The Rational Basis for Personalized Treatment Using Concentration-Guided DosingNick Holford, Zvonimir PetricTranslational and Clinical Pharmacology|March 6, 2020
Pharmacokinetic variability due to environmental differencesNick HolfordJournal of Pharmacokinetics and Pharmacodynamics|April 18, 2013
Disease progression and neuroscienceNick HolfordPharmaceutics|September 23, 2022
Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of BiosimilarsZvonimir Petric, Joao Goncalves, Paulo PaixaoTranslational and Clinical Pharmacology|February 26, 2020
Pharmacodynamic principles and the time course of immediate drug effectsNick HolfordActa Pharmaceutica (Zagreb, Croatia)|July 23, 2020
The controversies of parabens - an overview nowadaysZvonimir Petric, Julia Ružić, Irena ŽuntarBiomedicines|September 28, 2024
Infliximab in Inflammatory Bowel Disease: Leveraging Physiologically Based Pharmacokinetic Modeling in the Clinical ContextZvonimir Petric, João Gonçalves, Paulo PaixãoTranslational and Clinical Pharmacology|February 15, 2020
Pharmacodynamic principles and target concentration interventionNick HolfordBritish Journal of Clinical Pharmacology|May 30, 2013
Clinical pharmacology = disease progression + drug actionNick HolfordTranslational and Clinical Pharmacology|February 15, 2020
Pharmacodynamic principles and the time course of delayed and cumulative drug effectsNick HolfordPageof 5